Evidence Hub

Targeting breast cancer with 1,2,4-trioxanes: synthesis, cytotoxicity, and molecular docking insights

Yadav P, Shukla M, Kumar S, Pal S, Sen D, Rawat V, Shrivastava R, Prakash A et al.

RSC advances, 2026

Abstract

Breast cancer remains the most common malignancy among women to date, with increasing incidence and resistance to conventional therapies driving the search for novel treatments. 1,2,4-Trioxanes, known for their antimalarial activity, have emerged as promising anticancer agents due to their ability to generate reactive oxygen species (ROS) through iron-mediated activation, selectively inducing apoptosis in cancer cells. In this study, a series of hydroxy-functionalized and hemi-succinate trioxane derivatives were synthesized and evaluated against the MCF-7 breast cancer cell line. Among them, compound 10b3 showed the highest potency with an IC50 of 0.642 µM, outperforming the reference drug doxorubicin (IC50 = 0.857 µM). To complement the experimental findings, Boltz-2-guided binding affinity prediction was employed to estimate protein-ligand interaction free energies, enabling rapid and accurate assessment of binding strength beyond conventional scoring approaches. To explore the probable iron-mediated activation mechanism molecular docking experiments were further conducted to investigate binding orientation, active-site interactions, and the spatial proximity of the endoperoxide bridge to the catalytic iron atom. The compounds preferentially occupied hydrophobic pockets within the active site, stabilized mainly by hydrophobic contacts along with occasional hydrogen-bonding interactions. Notably, compound 10b3 exhibited a favourable binding orientation and interaction…

How strong is the evidence?

Evidence Hub reads this as a experimental / empirical study, done in cell cultures (in vitro) and computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free